KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $59.8 million.

  • GoodRx Holdings' Free Cash Flow fell 1629.27% to $59.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.4 million, marking a year-over-year increase of 1939.09%. This contributed to the annual value of $114.8 million for FY2024, which is 3735.36% up from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Free Cash Flow is $59.8 million, which was down 1629.27% from $31.7 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Free Cash Flow registered a high of $71.4 million during Q3 2024, and its lowest value of -$12.3 million during Q1 2025.
  • Over the past 5 years, GoodRx Holdings' median Free Cash Flow value was $28.3 million (recorded in 2024), while the average stood at $27.5 million.
  • As far as peak fluctuations go, GoodRx Holdings' Free Cash Flow surged by 72998.53% in 2024, and later tumbled by 15505.85% in 2025.
  • Over the past 5 years, GoodRx Holdings' Free Cash Flow (Quarter) stood at $41.4 million in 2021, then crashed by 59.53% to $16.7 million in 2022, then tumbled by 79.66% to $3.4 million in 2023, then surged by 729.99% to $28.3 million in 2024, then soared by 111.5% to $59.8 million in 2025.
  • Its last three reported values are $59.8 million in Q3 2025, $31.7 million for Q2 2025, and -$12.3 million during Q1 2025.